Relationship between the blood urea nitrogen to serum albumin ratio and in-hospital mortality in patients with type 2 diabetes mellitus complicated with ischemic stroke

血尿素氮/血清白蛋白比值与2型糖尿病合并缺血性卒中患者院内死亡率的关系

阅读:1

Abstract

BACKGROUND: Type 2 diabetes mellitus (T2DM) complicated with ischemic stroke is a major challenge to global public health and is related to poor prognosis. However, the role of blood urea nitrogen(BUN)to serum albumin ratio (BAR) in predicting in-hospital mortality of T2DM patients with ischemic stroke has not been fully explored. This study was carried out to investigate the relationship between BAR level and in-hospital mortality of T2DM patients with ischemic stroke. METHODS: The MIMIC-IV database was searched for data on T2DM patients with ischemic stroke. The primary outcome was in-hospital mortality. The BAR was calculated as follows: BUN (mg/dl)/ serum albumin (g/dl). Logistic regression was employed to investigate the relationship between BAR and in-hospital mortality of T2DM patients with ischemic stroke. The restricted cubic spline (RCS) was leveraged to examine the dose-response relationship of BAR with the outcome. The receiver operating characteristic (ROC) curve was utilized to measure the ability of BAR to predict the outcome. In addition, the decision curve analysis (DCA) was employed to explore the value of BAR in clinical practice. The consistency and robustness of the research results were assessed by subgroup analysis and the presence of interactions using a likelihood ratio test. RESULTS: Finally, 1136 patients were included for evaluation in this study. As BAR levels increased, the in-hospital mortality of T2DM patients with ischemic stroke also increased (OR:1.06; 95% CI:1.01-1.11; P < 0.01). The RCS analysis suggested that there was a linear relationship between BAR and in-hospital mortality of T2DM patients with ischemic stroke (p = 0.276). The ROC curve indicated that BAR was superior to BUN, Sepsis-related Organ Failure Assessment (SOFA), and Glasgow Coma Scale (GCS) in predicting the in-hospital mortality of T2DM patients with ischemic stroke. The DCA curve indicated that the net benefit of BAR was better than BUN, SOFA, and GCS. Subgroup analysis showed that there was no interaction between BAR and each subgroup (all p-value > 0.05). CONCLUSION: The in-hospital mortality of T2DM patients with ischemic stroke increased with elevated BAR levels.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。